Across multiethnic cohorts and meta‐analyses, IL‐6 remains an independent predictor of incident stroke in diabetes; adding IL‐6 to clinical models yields small but reproducible improvements in risk prediction, supporting its use in multimarker panels. The gene discussed is IL6; the disease is stroke disorder.